RLAY Earnings

Quarterly EPS
$-0.63
Q3 2024
$-0.45
Q4 2024
$-0.46
Q1 2025
$-0.41
Q2 2025
$-0.43
Q3 2025
$-0.32
Q4 2025
$-0.41
Q1 2026
$-0.41
Q2 2026
Latest Revenue350.0K
Latest Net Income-83707000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.41350.0K-83707000-48.3%+0.0%
Q1 2026-$0.413.0M-73291000-60.9%+10.9%
Q4 2025-$0.327.0M-54890000+28.9%
Q3 2025-$0.430-74149000+31.7%
Q2 2025-$0.41677.0K-70375000+40.6%
Q1 2025-$0.467.7M-77065000-23.3%+25.8%
Q4 2024-$0.450-76004000
Q3 2024-$0.630-88105000-100.0%-16.7%
Q2 2024-$0.690-92212000
Q1 2024-$0.6210.0M-81387000
Q4 2023
Q3 2023-$0.5425.2M-65734000
Relay Therapeutics (RLAY) — Earnings